Demographic changes in pelvic fracture patterns at a Swiss academic trauma center from 2007 to 2017 - Villiger K, Meier MK, Hasler RM, Bastian JD, Tannast M, Exadaktylos AK, Steppacher SD.
BACKGROUND: Increasing life expectancy has led to higher incidence of fragility fractures of the pelvis. These demographic changes may have a direct impact on fracture patterns. The goal was (1) to evaluate demographical trends in patients with pelvic ring... (Source: SafetyLit)
Source: SafetyLit - September 27, 2021 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Switzerland votes to legalize same-sex marriage
The country, among the last in Western Europe to grant full marriage rights, will also allow same-sex couples to adopt children and use... (Source: Reuters: Health)
Source: Reuters: Health - September 27, 2021 Category: Consumer Health News Source Type: news

Same-sex marriage referendum approved by wide margin in Switzerland
Switzerland has become one of the last Western European countries to make same-sex marriage legal, (Source: Reuters: Health)
Source: Reuters: Health - September 26, 2021 Category: Consumer Health News Source Type: news

Swiss Voters Approve Law Allowing Same-Sex Marriages
The legislation, endorsed in a referendum, will also allow same-sex couples to use sperm banks and to adopt children for the first time. (Source: Reuters: Health)
Source: Reuters: Health - September 26, 2021 Category: Consumer Health News Source Type: news

Swiss Voters Approve Same-Sex Marriage In A Nationwide Referendum
(Source: Reuters: Health)
Source: Reuters: Health - September 26, 2021 Category: Consumer Health News Source Type: news

Swiss look set to accept same-sex marriage in referendum
Swiss voters on Sunday looked set to back a proposal to open civil marriage and the right to adopt children to same-sex couples,... (Source: Reuters: Health)
Source: Reuters: Health - September 26, 2021 Category: Consumer Health News Source Type: news

Swiss to vote on allowing same-sex marriage in referendum
Voters in Switzerland, one of the last Western European countries that still bans gay marriage, will decide in a referendum on Sunday... (Source: Reuters: Health)
Source: Reuters: Health - September 26, 2021 Category: Consumer Health News Source Type: news

ASSIP: a new therapy following suicide attempt - Keller R, Saillant S, Gysin-Maillart A, Michaud L.
Although patients attempting suicide represent a highly vulnerable population, are often reluctant to care and at high risk of repetition, no specific therapy exist for them in French-speaking Switzerland. ASSIP( ®) (Attempted Suicide Short Intervention Pr... (Source: SafetyLit)
Source: SafetyLit - September 24, 2021 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

DiNAQOR Appoints Medical Device Leader Mark Dehdashtian to Oversee New U.S.-Based Division, Device Development and Production
ZURICH-SCHLIEREN, Switzerland and LAGUNA HILLS, Calif., Sept. 23, 2021 -- (Healthcare Sales & Marketing Network) -- DiNAQOR, a genetic medicine platform company focused on addressing severe inherited cardiac diseases, today announced it has expanded its l... Devices, Personnel DiNAQOR, genetic medicine (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 23, 2021 Category: Pharmaceuticals Source Type: news

Meet the 14-Year-Old Girl Whose Solar-Powered Invention Is a Finalist for Prince William ’s Earthshot Prize
Tell Vinisha Umashankar that your teen years pale in comparison to hers, and she is quick to remind you that everyone has a different life journey. But the 14-year-old also knows that the future looks very different for her generation if the world doesn’t act to slow global warming and the effects of climate change. Still, she’s optimistic that “collective action” of people her age will turn the tide. That’s probably why Umashankar has already been doing more than her fair share. In Tiruvannamalai, a small temple town in the southern Indian state of Tamil Nadu, she designed an ingenious sola...
Source: TIME: Science - September 23, 2021 Category: Science Authors: Abhishyant Kidangoor Tags: Uncategorized biztech2030 climate change India overnight TIME 2030 Source Type: news

Covid may be an occasional trigger of rare Guillain-Barré syndrome
Research of Guillain-Barré syndrome patients in China, France, Greece, Italy, the Netherlands, Spain, Switzerland, and the UK suggests there is a correlation between Covid infection and the condition. (Source: the Mail online | Health)
Source: the Mail online | Health - September 23, 2021 Category: Consumer Health News Source Type: news

Straumann Group and Aspen Dental Management, Inc., partner to offer dental implants and prosthetic solutions to over 1,000 locations across the U.S.
Agreement expands access to innovative products, integrated digital workflows and education for Aspen Dental and ClearChoice Dental Implant CentersANDOVER, Mass., Sept. 8, 2021 /PRNewswire/ -- Straumann Group, a global leader in tooth replacement and orthodontic solutions that restore smiles and confidence, announces a strategic partnership with Aspen Dental Management, Inc., (ADMI) to offer dental implant solutions, abutments and CAD/CAM options to more than 1000 ADMI and affiliated offices across 45 U.S. states.The partnership includes Aspen Dental, one of the largest and fastest growing branded netwo...
Source: Dental Technology Blog - September 18, 2021 Category: Dentistry Source Type: news

Africa: Meet Africa's New Generation of Health Innovators
[New Dawn] DAKAR, Senegal/GENEVA, Switzerland, 16 September 2021 -/African Media Agency(AMA)/- The International Federation of Pharmaceutical Manufacturers& Associations (IFPMA) and Speak Up Africa, have announced Conrad Tankou, CEO, GIC Space (Cameroon); John Mwangi, CEO, Daktari Media (Kenya) and Imodoye Abioro, CEO, Healthbotics (Nigeria) as the winners of the Africa Young Innovators for Health Award. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - September 17, 2021 Category: African Health Source Type: news

Heat-related cardiovascular morbidity and mortality in Switzerland: a clinical perspective - Schulte F, R öösli M, Ragettli MS.
AIMS: Previous studies found increased cardiovascular mortality during hot days, while emergency hospital admissions were decreasing. We explored potential underlying reasons by analysing clinically similar cardiovascular disease groups taking into account... (Source: SafetyLit)
Source: SafetyLit - September 16, 2021 Category: International Medicine & Public Health Tags: Environmental Issues, Climate, Geophysics Source Type: news

COVID-19 Recovery Requires Justice Beyond Rhetoric
Credit: Global Policy ForumBy Jens MartensBONN, Germany, Sep 16 2021 (IPS) Policy responses to the COVID-19 pandemic and resulting economic crisis have exacerbated rather than reduced global inequalities. On the one hand, the net wealth of billionaires has risen to record levels since the outbreak of the pandemic (increasing by more than US$ 5 trillion to US$ 13.1 trillion from 2020 to 2021), on the other hand, the number of people living in extreme poverty has also increased massively (by approx. 100 million to 732 million in 2020). These contrasts alone show that something is fundamentally wrong in the world. In respon...
Source: IPS Inter Press Service - Health - September 16, 2021 Category: International Medicine & Public Health Authors: Jens Martens Tags: Civil Society Economy & Trade Education Gender Global Headlines Health Humanitarian Emergencies Poverty & SDGs TerraViva United Nations Women & Economy Source Type: news

"Israel is not Switzerland": the impact of political violence in Israel on historically traumatized Argentinian immigrants - Gal S.
This study explores the long-term impact of childhood political trauma on the lives of adult Jewish-Argentinian immigrants who experienced trauma during the military dictatorship in Argentina (1976-1983), and who subsequently immigrated to Israel. Given th... (Source: SafetyLit)
Source: SafetyLit - September 15, 2021 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Mesothelioma Research, COVID Findings Featured at IASLC Conference
This study, performed during the pre-vaccine period of the pandemic, once again demonstrates the importance of vaccination against COVID-19,” said Dr. Susana Cedres, a medical oncologist with Vall d’Hebron Hospital. “Malignant pleural mesothelioma patients are particularly vulnerable to COVID-19.” Cedres said since the subsequent rollout of the COVID-19 vaccines, no positive cases have been attributed to pleural mesothelioma patients at the hospital. The average age of the seven patients was 62. All had the epithelioid histology of mesothelioma and two were receiving oncologic treatment at the...
Source: Asbestos and Mesothelioma News - September 15, 2021 Category: Environmental Health Authors: Fran Mannino Source Type: news

Rolled ham and Swiss omelet
(Source: MayoClinic.com Full Feed)
Source: MayoClinic.com Full Feed - September 14, 2021 Category: Consumer Health News Source Type: news

Major trauma during COVID-19 in a level 1 trauma centre in Switzerland - a cohort study comparing the years 2020 and 2019 - Anwander H, Klingberg K, Gerber J, Bednarski P, Exadaktylos A, Muller M.
INTRODUCTION: The COVID-19 pandemic and the associated restrictions may have modified the activities of the Swiss population and thus altered trauma patterns. MATERIALS AND PATIENTS: All adult patients with major trauma admitted to our institution in 2019 ... (Source: SafetyLit)
Source: SafetyLit - September 13, 2021 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

Modelling transport time to trauma centres and 30-day mortality in road accidents in Switzerland: an exploratory study - Diserens RV, Marmy C, Pasquier M, Zingg T, Joost S, Hugli O.
BACKGROUND: Rapid access to a trauma centre for severely injured road accident victims, conceptualised as the Golden Hour, links access time to definitive treatment within 1 hour of trauma with reduced risks of morbidity and mortality. Access times have no... (Source: SafetyLit)
Source: SafetyLit - September 10, 2021 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

COVAX Was a Great Idea, But Is Now 500 Million Doses Short of Its Vaccine Distribution Goals. What Exactly Went Wrong?
In January 2020, world leaders and industry titans gathered in Switzerland for the World Economic Forum’s annual Davos conference. Much of the conversation centered around the mysterious new coronavirus that had emerged in Wuhan, China, a month earlier, and had at that point infected nearly 300 people in four countries. Two of the conference’s attendees were Dr. Seth Berkley, CEO of Gavi, the Vaccine Alliance, and Dr. Richard Hatchett, CEO of the Coalition for Epidemic Preparedness Innovations (CEPI). Over scotch and nachos one night, Berkley and Hatchett got to talking about worst-case scenarios. “&lsquo...
Source: TIME: Health - September 9, 2021 Category: Consumer Health News Authors: Jamie Ducharme Tags: Uncategorized COVID-19 healthscienceclimate Source Type: news

atHeart Medical Appoints Seasoned Medtech Executive Andrew Cleeland to Board of Directors
BAAR, Switzerland and MOUNTAIN VIEW, Calif., Sept. 8, 2021 -- (Healthcare Sales & Marketing Network) -- atHeart Medical, a medical device company dedicated to establishing the new standard of care for closure of atrial septal defects (ASD), today announce... Devices, Cardiology, Personnel atHeart Medical, reSept ASD Occluder, atrial septal defect (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - September 8, 2021 Category: Pharmaceuticals Source Type: news

The role of moral neutralization of aggression and justification of violence against women in predicting physical teen dating violence perpetration and monitoring among adolescents in Switzerland - Schuster I, Tomaszewska P, Gul P, Ribeaud D, Eisner M.
Although dating violence poses a serious threat to adolescents' health and well-being around the globe, little evidence is available for Europe in general and Switzerland in particular. Also, evidence on the role of cognitive predictors related to a more g... (Source: SafetyLit)
Source: SafetyLit - September 6, 2021 Category: International Medicine & Public Health Tags: Age: Adolescents Source Type: news

Second-look PET/CT catches cancer spread
Is a second PET/CT scan worth it before radiotherapy treatment? Swiss clinician...Read more on AuntMinnie.comRelated Reading: PET/CT shows promise predicting outcomes in head, neck cancer AI algorithm produces autosegmented contours for radiotherapy Can 3D-printed shields protect patients during radiation therapy? PET/MRI boosts cancer detection PET/MRI ups lesion detection by 15% for some cancers (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - September 2, 2021 Category: Radiology Source Type: news

Rare disease company EnBiotix merges with Swiss firm
EnBiotix Inc., a Boston-based biotech focused on rare diseases, is merging with Swiss oncology and antimicrobial resistance-focused company Polyphor. Under the terms of the agreement, Polyphor will acquire all of EnBiotix's outstanding capital stock; EnBiotix will in turn acquire the rights to inhaled murepavadin, a potent antibiotic that targets multi-drug resistant Pseudomonas aeruginosa infections in cystic fibrosis patients, for $10 million . The merger is expected to close in the fourth quarter… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - September 1, 2021 Category: Pharmaceuticals Authors: Rowan Walrath Source Type: news

Rare disease company EnBiotix merges with Swiss firm
EnBiotix Inc., a Boston-based biotech focused on rare diseases, is merging with Swiss oncology and antimicrobial resistance-focused company Polyphor. Under the terms of the agreement, Polyphor will acquire all of EnBiotix's outstanding capital stock; EnBiotix will in turn acquire the rights to inhaled murepavadin, a potent antibiotic that targets multi-drug resistant Pseudomonas aeruginosa infections in cystic fibrosis patients, for $10 million . The merger is expected to close in the fourth quarter… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - September 1, 2021 Category: Biotechnology Authors: Rowan Walrath Source Type: news

Hi-tech wooden flooring can turn footsteps into electricity
Swiss scientists develop prototype ‘nanogenerator’ that produces renewable energy when trodden onScientists have developed technology that can turn footsteps into electricity.By tapping into an unexpected energy source, wooden flooring, researchers from Switzerland have developed an energy harvesting device that uses wood with a combination of a silicone coating and embedded nanocrystals to produce enough energy to power LED lightbulbs and small electronics.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - September 1, 2021 Category: Science Authors: Natalie Grover Science correspondent Tags: Renewable energy Environment Science World news Source Type: news

Swiss diet and lifestyle coaching app Oviva raises €67M in Series C funding
The digital health scaleup uses individual coaching with an intuitive app and certified dietitians to deliver healthy eating programmes.   (Source: mobihealthnews)
Source: mobihealthnews - September 1, 2021 Category: Information Technology Source Type: news

Coronavirus latest: US raises travel alert levels for Switzerland, Canada and Germany
(Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - August 30, 2021 Category: Pharmaceuticals Source Type: news

Just Starting Exercise in Your 60s? It'll Still Do a World of Good
WEDNESDAY, Aug. 25, 2021 -- If you're a 60-something with heart disease, it's not too late to give your ticker the benefits of a regular workout. Swiss researchers found that survival rates among heart patients who became active later in life were... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - August 25, 2021 Category: General Medicine Source Type: news

FDA Approves Korsuva (difelikefalin) Injection for the Treatment of Moderate-to-Severe Pruritus in Hemodialysis Patients
STAMFORD, Conn. and ST. GALLEN, Switzerland, Aug. 23, 2021 (GLOBE NEWSWIRE) -- Cara Therapeutics (Nasdaq: CARA) and Vifor Pharma today announced that the U.S. Food and Drug Administration (FDA) has approved Korsuva (difelikefalin) for injection for... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - August 23, 2021 Category: Drugs & Pharmacology Source Type: news

Crevasse accidents in the Swiss Alps: epidemiology and mortality of 405 victims of crevasse accidents from 2010 to 2020 - Klocker E, Meuli L, Rauch S, Kottmann A, Mosimann U, Pasquier M, M étrailler P, Doppman P, Albrecht R, Pietsch U.
INTRODUCTION: The clinical spectrum of injuries in crevasse accidents can range from benign to life-threatening, even including death. To date, little is known about incidence and causes. METHODS: We retrospectively analyzed mountain rescue mission... (Source: SafetyLit)
Source: SafetyLit - August 23, 2021 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

More made-up science: Chinese state media walks back claims made by fabricated "Swiss biologist"
(Natural News) Chinese state media has quietly scrubbed reports of an alleged Swiss biologist criticizing the United States’ efforts to investigate the origins of the Wuhan coronavirus (COVID-19) pandemic. This was after the Swiss embassy in Beijing said that, according to their records, said biologist was likely not a real person. The supposed Swiss biologist, named Wilson... (Source: NaturalNews.com)
Source: NaturalNews.com - August 18, 2021 Category: Consumer Health News Source Type: news

Roche receives FDA approval for first companion diagnostic to identify dMMR solid tumour patients eligible for anti-PD-1 immunotherapy
Basel, 18 August 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced U.S. Food and Drug Administration (FDA) approval of the VENTANA MMR RxDx Panel, advancing the company's commitment to personalised healthcare through tests that determine which patients are most likely to benefit from specific and targeted therapies. The VENTANA MMR RxDx Panel is the first companion diagnostic test to aid in identifying patients whose solid tumours are deficient in DNA mismatch repair (MMR), who may be eligible for JEMPERLI (dostarlimab-gxly) monotherapy, an anti-PD-1 immunotherapy from GSK. The test evaluates a panel of MMR p...
Source: Roche Media News - August 18, 2021 Category: Pharmaceuticals Source Type: news

Roche receives FDA approval for first companion diagnostic to identify dMMR solid tumour patients eligible for anti-PD-1 immunotherapy
Basel, 18 August 2021 – Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced U.S. Food and Drug Administration (FDA) approval of the VENTANA MMR RxDx Panel, advancing the company's commitment to personalised healthcare through tests that determine which patients are most likely to benefit from specific and targeted therapies. The VENTANA MMR RxDx Panel is the first companion diagnostic test to aid in identifying patients whose solid tumours are deficient in DNA mismatch repair (MMR), who may be eligible for JEMPERLI (dostarlimab-gxly) monotherapy, an anti-PD-1 immunotherapy from GSK. The test evaluates a panel of MMR p...
Source: Roche Investor Update - August 18, 2021 Category: Pharmaceuticals Source Type: news

New mathematical record: what ’s the point of calculating pi?
The famous number has many practical uses, mathematicians say, but is it really worth the time and effort to work out its trillions of digits?Swiss researchers have spent 108 days calculating pi to a new record accuracy of62.8tn digits.Using a computer, their approximation beat the previous world record of 50tn decimal places, and was calculated 3.5 times as quickly. It ’s an impressive and time-consuming feat that begs the question: why?Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - August 17, 2021 Category: Science Authors: Donna Lu Tags: Mathematics Pi Science World news Australia news Source Type: news

Swiss researchers calculate pi to new record of 62.8tn figures
Supercomputer calculation took 108 days and nine hours – 3.5 times as fast as previous recordSwiss researchers have calculated the mathematical constantpi to a new world-record level of exactitude, hitting 62.8tn figures using a supercomputer.“The calculation took 108 days and nine hours,” the Graubuenden University of Applied Sciences said in a statement.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - August 16, 2021 Category: Science Authors: AFP in Geneva Tags: Mathematics Science Switzerland Europe Guinness World Records Pi World news Source Type: news

Occlutech granted important conditional FDA approval for PFO Study (OCCLUFLEX) in the U.S.
SCHAFFHAUSEN, Switzerland, Aug. 16, 2021 -- (Healthcare Sales & Marketing Network) -- Occlutech Holding AG ("Occlutech"), one of the world´s leading providers of minimally invasive structural heart disease devices, announces the conditiona... Devices, Interventional, Cardiology, FDA Occlutech, Flex II, PFO Occluder (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - August 16, 2021 Category: Pharmaceuticals Source Type: news

Dermavant Announces FDA Acceptance for Filing of New Drug Application (NDA) for Tapinarof Cream for the Treatment of Adults with Plaque Psoriasis
LONG BEACH, Calif.& BASEL, Switzerland--(BUSINESS WIRE) August 10, 2021 --Dermavant Sciences, a clinical-stage biopharmaceutical company dedicated to developing and commercializing innovative therapeutics in immuno-dermatology, today announced... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - August 10, 2021 Category: Drugs & Pharmacology Source Type: news

Duke Study Suggests Radiation Does Not Extend Mesothelioma Survival
A dual registry analysis by the esteemed Duke University Medical Center has concluded that adjuvant hemithoracic radiation does not improve survival when combined with aggressive surgery for patients with malignant pleural mesothelioma. Although the U.S. National Comprehensive Cancer Network and the European Society for Medical Oncology recommend the adjuvant radiation – as do many specialists – the Duke research team has challenged the conventional treatment with this report. “The receipt of adjuvant hemithoracic radiation was not associated with improved survival when compared to no radiation,&rdq...
Source: Asbestos and Mesothelioma News - August 9, 2021 Category: Environmental Health Authors: Fran Mannino Source Type: news

Thailand man charged over death of Swiss tourist near waterfall
The 27-year-old man has been charged with murdering the 57-year-old woman. (Source: Reuters: Health)
Source: Reuters: Health - August 9, 2021 Category: Consumer Health News Source Type: news

[Ad hoc announcement pursuant to Art. 53 LR] Phase III study shows Roche's Polivy plus R-CHP is the first regimen in 20 years to significantly improve outcomes in previously untreated aggressive form of lymphoma compared to standard of care
Basel, 9 August 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the pivotal phase III POLARIX trial investigating Polivy ® (polatuzumab vedotin) in combination with MabThera®/Rituxan® (rituximab) plus cyclophosphamide, doxorubicin and prednisone (R-CHP) versus MabThera/Rituxan plus cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP), met its primary endpoint by demonstrating significantly improved an d clinically meaningful progression-free survival in people with previously untreated diffuse large B-cell lymphoma (DLBCL). Safety outcomes were consistent with those seen in previous...
Source: Roche Media News - August 9, 2021 Category: Pharmaceuticals Source Type: news

[Ad hoc announcement pursuant to Art. 53 LR] Phase III study shows Roche's Polivy plus R-CHP is the first regimen in 20 years to significantly improve outcomes in previously untreated aggressive form of lymphoma compared to standard of care
Basel, 9 August 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the pivotal phase III POLARIX trial investigating Polivy ® (polatuzumab vedotin) in combination with MabThera®/Rituxan® (rituximab) plus cyclophosphamide, doxorubicin and prednisone (R-CHP) versus MabThera/Rituxan plus cyclophosphamide, doxorubicin, vincristine and prednisone (R-CHOP), met its primary endpoint by demonstrating significantly improved an d clinically meaningful progression-free survival in people with previously untreated diffuse large B-cell lymphoma (DLBCL). Safety outcomes were consistent with those seen in previous...
Source: Roche Investor Update - August 9, 2021 Category: Pharmaceuticals Source Type: news

SoftBank/Roche: Northstar reorients to embrace drug development
The Swiss company and Japanese tech investor both have a taste for big data and disruption (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - August 4, 2021 Category: Pharmaceuticals Source Type: news

‘ Don ’t Forget Leprosy ’ Campaign Amid COVID-19 Pandemic
Yohei Sasakawa, WHO Goodwill Ambassador for Leprosy Elimination answers questions from Patricia Soares, a guest at the launch of the ‘Don’t Forget Leprosy’ campaign. They are with Takahiro Nanri, Executive Director of the Sasakawa Health Foundation. Credit: Cecilia Russell By Cecilia RussellJOHANNESBURG, SOUTH AFRICA, Aug 4 2021 (IPS) A visit to a leprosy facility in Korea with his father, Ryoichi Sasakawa, spurred Yohei Sasakawa to dedicate his life to eliminating both the disease and discrimination of those affected. He was speaking in an emotional pre-recorded address ahead of his 20th anniversary as ...
Source: IPS Inter Press Service - Health - August 4, 2021 Category: International Medicine & Public Health Authors: Cecilia Russell Tags: COVID-19 Development & Aid Featured Global Headlines Health Human Rights Humanitarian Emergencies Inequity TerraViva United Nations Asian Population and Development Association (APDA) leprosy Nippon Foundation Sasakawa Health Fou Source Type: news

SoftBank acquires $5bn stake in Swiss drugmaker Roche
Deal struck through unit of Japanese technology group that was behind ‘Nasdaq whale’ trade (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - August 4, 2021 Category: Pharmaceuticals Source Type: news

Genentech requiring Covid vaccination for workforce
Biotech giant Genentech Inc. has joined the growing list of employers requiring workers to be vaccinated against Covid-19. With limited exceptions for medical and religious reasons, the 13,000-employee South San Francisco-based U.S. biotech unit of Swiss drug giant said it would "follow the science" to help beat back the pandemic. Nearly 200 million cases of Covid-19, which is caused by the SARS-CoV-2 virus setting l oose an immune system response that chokes off the lungs and other organs, have… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - August 3, 2021 Category: American Health Authors: Ron Leuty Source Type: news

Genentech requiring Covid vaccination for workforce
Biotech giant Genentech Inc. has joined the growing list of employers requiring workers to be vaccinated against Covid-19. With limited exceptions for medical and religious reasons, the 13,000-employee South San Francisco-based U.S. biotech unit of Swiss drug giant said it would "follow the science" to help beat back the pandemic. Nearly 200 million cases of Covid-19, which is caused by the SARS-CoV-2 virus setting l oose an immune system response that chokes off the lungs and other organs, have… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - August 3, 2021 Category: Biotechnology Authors: Ron Leuty Source Type: news

US FDA grants Priority Review to Roche ’s Tecentriq as adjuvant treatment for certain people with early non-small cell lung cancer
Basel, 3 August 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the US Food and Drug Administration (FDA) has accepted the company ’s supplemental Biologics License Application (sBLA) and granted Priority Review for Tecentriq® (atezolizumab) as adjuvant treatment following surgery and platinum-based chemotherapy for people with non-small cell lung cancer (NSCLC) whose tumours express PD-L1≥1%, as determined by an FDA-appro ved test. The FDA is reviewing the application under the Real-Time Oncology Review pilot programme, which aims to explore a more efficient review process to ensure safe and ef...
Source: Roche Media News - August 3, 2021 Category: Pharmaceuticals Source Type: news

US FDA grants Priority Review to Roche ’s Tecentriq as adjuvant treatment for certain people with early non-small cell lung cancer
Basel, 3 August 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that the US Food and Drug Administration (FDA) has accepted the company ’s supplemental Biologics License Application (sBLA) and granted Priority Review for Tecentriq® (atezolizumab) as adjuvant treatment following surgery and platinum-based chemotherapy for people with non-small cell lung cancer (NSCLC) whose tumours express PD-L1≥1%, as determined by an FDA-appro ved test. The FDA is reviewing the application under the Real-Time Oncology Review pilot programme, which aims to explore a more efficient review process to ensure safe and ef...
Source: Roche Investor Update - August 3, 2021 Category: Pharmaceuticals Source Type: news